Atlas Trials

Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia

Clinical trial NCT03548155 · COMPLETED

Trial details

NCT number
NCT03548155
Sponsor
Tianjin Anding Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SchizophreniaTherapeutics
Start date
2014-07-24
Primary completion
2015-12-14
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.